Principal Scientist visa sponsorship salary
Across 91 certified work-visa filings, the median wage for Principal Scientist is $135,000. The middle half of filings fall between $111,374 and $157,063, and the top decile begins at $172,100. Classified under SOC 19-1042.00 (Medical Scientists, Except Epidemiologists).
This is one of many job titles filed under Medical Scientists, Except Epidemiologists. That page pools every variant, so its figures rest on far more filings than this one.
- Median
- $135,000
- 25th pct
- $111,374
- 75th pct
- $157,063
- 90th pct
- $172,100
- Filings
- 91
Who pays what for Principal Scientist
Ranked by number of certified filings
| Employer | Filings | 25th | Median | 75th |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 12 | $152,975 | $155,376 | $162,804 |
| Bristol-Myers Squibb Company | 6 | $146,939 | $154,088 | $159,901 |
| Eli Lilly and Company | 6 | $116,933 | $119,110 | $120,228 |
| Pfizer INC. | 6 | $102,900 | $105,000 | $107,099 |
| Calder Biosciences Inc. | 2 | $153,001 | $153,002 | $153,004 |
| Zoetis, Inc. | 2 | $129,000 | $133,000 | $137,000 |
| Sanofi US Services Inc. | 2 | $125,753 | $129,256 | $132,758 |
| Pharmavite LLC | 2 | $115,250 | $124,500 | $133,750 |
| BrickBio Inc. | 2 | $114,317 | $118,415 | $122,512 |
| ElectraTect, Inc. | 2 | $112,237 | $112,237 | $112,237 |
| Riconpharma, LLC | 2 | $109,750 | $111,500 | $113,250 |
| American Cancer Society, INC. | 2 | $110,510 | $110,510 | $110,510 |
| GlaxoSmithKline LLC | 2 | $98,813 | $100,125 | $101,438 |
| JangoBio LLC | 2 | $70,209 | $72,418 | $74,626 |
Individual filings
Most recent certified determinations
| Employer | Location | Wage | Level | Decided |
|---|---|---|---|---|
| Repertoire Immune Medicines, Inc. | Cambridge, MA | $180,000 | IV | Sep 24, 2025 |
| Riconpharma, LLC | Denville, NJ | $115,000 | III | Sep 24, 2025 |
| Eli Lilly and Company | Boston, MA | $130,000 | III | Sep 17, 2025 |
| American Cancer Society, INC. | Houston, TX | $110,510 | III | Sep 12, 2025 |
| Yemaya, Inc. | Palo Alto, CA | $190,000 | III | Aug 29, 2025 |
| American Cancer Society, INC. | Houston, TX | $110,510 | III | Aug 7, 2025 |
| Merck Sharp & Dohme LLC | Rahway, NJ | $187,000 | IV | Aug 6, 2025 |
| Tulex Pharmaceuticals Inc. | Cranbury, NJ | $115,000 | IV | Aug 5, 2025 |
| Bristol-Myers Squibb Company | Princeton, NJ | $159,984 | III | Aug 4, 2025 |
| Eli Lilly and Company | Branchburg, NJ | $119,110 | III | Aug 4, 2025 |
| Eli Lilly and Company | New York, NY | $120,600 | III | Jul 28, 2025 |
| Adare Pharmaceuticals Inc. | Philadelphia, PA | $115,000 | IV | Jul 23, 2025 |
| Nobell Foods, Inc. | South San Francisco,, CA | $125,466 | IV | Jul 21, 2025 |
| Eli Lilly and Company | Branchburg, IN | $119,110 | III | Jul 18, 2025 |
| Regeneron Pharmaceuticals, Inc. | Tarrytown, NY | $172,500 | IV | Jul 16, 2025 |
| TCG GreenChem, Inc | Ewing, NJ | $103,967 | III | Jul 16, 2025 |
| Cyprotex US LLC | Framingham, MA | $169,289 | IV | Jul 14, 2025 |
| Eli Lilly and Company | New York, NY | $116,207 | III | Jul 7, 2025 |
| Sanofi US Services Inc. | Cambridge, MA | $136,261 | IV | Jul 7, 2025 |
| Eli Lilly and Company | New York, NY | $116,207 | III | Jul 3, 2025 |
| ElectraTect, Inc. | Phoenix, AZ | $112,237 | III | Jun 24, 2025 |
| The Children's Hospital of Philadelphia | Philadelphia, PA | $72,238 | II | Jun 20, 2025 |
| Boehringer Ingelheim Pharmaceuticals, INC. | Ridgefield, CT | $183,475 | IV | Jun 20, 2025 |
| Pfizer INC. | Somerset, NJ | $102,900 | II | Jun 18, 2025 |
| Pfizer INC. | Andover, MA | $127,000 | III | Jun 18, 2025 |
Prevailing wage levels I through IV reflect the experience and responsibility the employer attested to, not seniority titles. A level I filing is an entry-level determination; level IV is fully competent and independent. Comparing across levels explains much of the spread between the 25th and 90th percentile above.